Oksuz E, et al
Moreover, their therapeutic utility is often constrained by side effects and poor long-term outcomes, highlighting the urgent need for mechanistically novel treatments that can effectively address the positive, negative, and cognitive symptoms of schizophrenia (Remington et al., 2016)
"Not all medicines work the same for all patients," Ilya Yuffa, executive vice president and president of Lilly USA and global customer capabilities, said in the release
Proton Pump Inhibitors (PPIs): For more persistent reflux, a provider might suggest a PPI to significantly lower acid production
Type 2 diabetes and glucagon-like peptide-1 receptor agonists Type 2 diabetes is a chronic adverse health condition in which the body either resists the effects of insulin or does not produce enough to keep blood sugar at normal levels
Do not attempt to self-assess whether a preparation is safe to use following a suspected storage failure